HUP0201549A3 - Quinolinecarboxylic acid derivative or salts thereof and pharmaceutical compositions containing them - Google Patents
Quinolinecarboxylic acid derivative or salts thereof and pharmaceutical compositions containing themInfo
- Publication number
- HUP0201549A3 HUP0201549A3 HU0201549A HUP0201549A HUP0201549A3 HU P0201549 A3 HUP0201549 A3 HU P0201549A3 HU 0201549 A HU0201549 A HU 0201549A HU P0201549 A HUP0201549 A HU P0201549A HU P0201549 A3 HUP0201549 A3 HU P0201549A3
- Authority
- HU
- Hungary
- Prior art keywords
- salts
- pharmaceutical compositions
- compositions containing
- acid derivative
- quinolinecarboxylic acid
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical class C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18749299 | 1999-07-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0201549A2 HUP0201549A2 (en) | 2002-08-28 |
| HUP0201549A3 true HUP0201549A3 (en) | 2003-11-28 |
Family
ID=16207019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0201549A HUP0201549A3 (en) | 1999-07-01 | 2000-06-22 | Quinolinecarboxylic acid derivative or salts thereof and pharmaceutical compositions containing them |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6858625B1 (hu) |
| EP (1) | EP1193266B1 (hu) |
| JP (1) | JP3477465B2 (hu) |
| KR (1) | KR100628414B1 (hu) |
| CN (1) | CN1157389C (hu) |
| AT (1) | ATE248162T1 (hu) |
| AU (1) | AU766014B2 (hu) |
| BR (1) | BR0012192A (hu) |
| CA (1) | CA2376760C (hu) |
| CZ (1) | CZ302033B6 (hu) |
| DE (1) | DE60004846T2 (hu) |
| DK (1) | DK1193266T3 (hu) |
| ES (1) | ES2206257T3 (hu) |
| HK (1) | HK1047103B (hu) |
| HU (1) | HUP0201549A3 (hu) |
| IL (2) | IL147043A0 (hu) |
| MX (1) | MXPA02000103A (hu) |
| NO (1) | NO321803B1 (hu) |
| NZ (1) | NZ516201A (hu) |
| PT (1) | PT1193266E (hu) |
| RU (1) | RU2236408C2 (hu) |
| SK (1) | SK285814B6 (hu) |
| TW (1) | TW576832B (hu) |
| WO (1) | WO2001002390A1 (hu) |
| ZA (1) | ZA200110357B (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3477466B2 (ja) | 1999-09-02 | 2003-12-10 | 湧永製薬株式会社 | キノリンカルボン酸誘導体又はその塩 |
| US7172535B2 (en) * | 2004-10-28 | 2007-02-06 | Volmar John F | Upper back exercise machine and method of use |
| MX2007005892A (es) | 2004-11-17 | 2007-06-19 | Wakunaga Pharma Co Ltd | Derivados de acido piridonacarboxilico novedosos y sales de los mismos. |
| US8497378B2 (en) * | 2008-09-24 | 2013-07-30 | Rib-X Pharmaceuticals, Inc. | Process for making quinolone compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO177302C (no) * | 1989-03-16 | 1995-08-23 | Esteve Labor Dr | Analogifremgangsmåte til fremstilling av terapeutisk aktive substituerte azetidinylkinolon(naftyridon)karboksylsyrederivater |
| CA2168764C (en) * | 1993-08-13 | 2000-01-18 | Sung June Yoon | Novel quinolone carboxylic acid derivatives |
| CA2290712C (en) * | 1995-09-22 | 2003-09-09 | Wakunaga Pharmaceutical Co., Ltd. | Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components |
| EP0897919B1 (en) * | 1996-04-19 | 2004-06-16 | Wakunaga Pharmaceutical Co., Ltd. | Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents containing the same as the active ingredient |
| KR100516379B1 (ko) | 1996-11-28 | 2005-09-26 | 와쿠나가 세이야쿠 가부시키 가이샤 | 신규 피리돈카르복실산 유도체 또는 그의 염 및 이를 유효 성분으로 하는 의약 |
| DE19652239A1 (de) * | 1996-12-16 | 1998-06-18 | Bayer Ag | Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen |
| JPH11292873A (ja) | 1998-04-07 | 1999-10-26 | Dainippon Pharmaceut Co Ltd | キノロンカルボン酸誘導体の製造方法およびその中間体 |
-
2000
- 2000-06-22 NZ NZ516201A patent/NZ516201A/xx unknown
- 2000-06-22 CN CNB008095884A patent/CN1157389C/zh not_active Expired - Fee Related
- 2000-06-22 CZ CZ20014598A patent/CZ302033B6/cs not_active IP Right Cessation
- 2000-06-22 AU AU55679/00A patent/AU766014B2/en not_active Ceased
- 2000-06-22 HU HU0201549A patent/HUP0201549A3/hu unknown
- 2000-06-22 CA CA002376760A patent/CA2376760C/en not_active Expired - Fee Related
- 2000-06-22 PT PT00940804T patent/PT1193266E/pt unknown
- 2000-06-22 BR BR0012192-4A patent/BR0012192A/pt not_active Application Discontinuation
- 2000-06-22 SK SK1916-2001A patent/SK285814B6/sk not_active IP Right Cessation
- 2000-06-22 WO PCT/JP2000/004096 patent/WO2001002390A1/ja active IP Right Grant
- 2000-06-22 EP EP00940804A patent/EP1193266B1/en not_active Expired - Lifetime
- 2000-06-22 KR KR1020017016021A patent/KR100628414B1/ko not_active IP Right Cessation
- 2000-06-22 ES ES00940804T patent/ES2206257T3/es not_active Expired - Lifetime
- 2000-06-22 DE DE60004846T patent/DE60004846T2/de not_active Expired - Lifetime
- 2000-06-22 JP JP2001507827A patent/JP3477465B2/ja not_active Expired - Fee Related
- 2000-06-22 AT AT00940804T patent/ATE248162T1/de not_active IP Right Cessation
- 2000-06-22 MX MXPA02000103A patent/MXPA02000103A/es active IP Right Grant
- 2000-06-22 US US10/019,436 patent/US6858625B1/en not_active Expired - Fee Related
- 2000-06-22 DK DK00940804T patent/DK1193266T3/da active
- 2000-06-22 RU RU2002102491/04A patent/RU2236408C2/ru not_active IP Right Cessation
- 2000-06-22 IL IL14704300A patent/IL147043A0/xx active IP Right Grant
- 2000-06-27 TW TW089112608A patent/TW576832B/zh not_active IP Right Cessation
-
2001
- 2001-12-12 IL IL147043A patent/IL147043A/en not_active IP Right Cessation
- 2001-12-18 ZA ZA200110357A patent/ZA200110357B/en unknown
- 2001-12-27 NO NO20016378A patent/NO321803B1/no not_active IP Right Cessation
-
2002
- 2002-11-29 HK HK02108684.2A patent/HK1047103B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0303810A3 (en) | Carboxylic acid derivative and salt thereof and pharmaceutical compositions containing them | |
| HUP0203378A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
| HUP0100178A3 (en) | Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof | |
| HUP0202254A3 (en) | Amide substituted imidazoquinolines and pharmaceutical compositions containing them | |
| HK1053638A1 (en) | Derivatives of dicarboxylic acid having pharmaceutical properties | |
| HUP0204283A3 (en) | Piperidine quinolyl propyl derivatives, preparation method and pharmaceutical compositions containing same | |
| HUP0105133A3 (en) | Quinoline derivatives and quinazoline derivatives, pharmaceutical compositions containing them and their use | |
| IL145732A0 (en) | α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| HUP0201068A3 (en) | Pharmaceutical compositions of erythropoietin | |
| HUP0202788A3 (en) | Indolyl-3-glyoxylic acid derivatives serving as antitumor agents and pharmaceutical compositions containing them | |
| EP1311477A4 (en) | NEW THIOCARBAMIDIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THEM | |
| HUP0202255A2 (en) | Crystalline 1-methylcarbapenem compounds and pharmaceutical compositions containing them | |
| HUP0201714A3 (en) | Substituted heterocyclic compounds and pharmaceutical compositions containing them | |
| HUP0105204A3 (en) | Substituted phenethylamine derivatives and pharmaceutical compositions containing them | |
| AU6827800A (en) | Aqueous pharmaceutical composition containing moxifloxacin or salts thereof | |
| HUP0000137A3 (en) | Controller-release pharmaceutical composition containing anangetics | |
| HUP0301080A3 (en) | Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0303184A3 (en) | Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them | |
| HUP0200747A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
| HUP0200468A3 (en) | Resorcinol derivatives and pharmaceutical compositions containing them | |
| IL159084A0 (en) | Tetrahydroisoquinoline carboxylic acid derivatives and pharmaceutical compositions containing the same | |
| IL148725A0 (en) | Aqueous pharmaceutical compositions containing circlesonide | |
| IL148106A0 (en) | Pharmaceutical compositions comprising 4-quinolones | |
| HUP0201549A3 (en) | Quinolinecarboxylic acid derivative or salts thereof and pharmaceutical compositions containing them | |
| HUP0001061A3 (en) | Naphthylsulfonic acid derivatives and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |